Spironolacton die beste Option bei „resistenter“ Hypertonie
Crossref DOI link: https://doi.org/10.1007/s15006-015-3504-5
Published Online: 2015-10-07
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Overbeck, Peter
Text and Data Mining valid from 2015-09-01